Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1056)
  3. Review (108)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (11)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2465)
  2. Solid Tumor Oncology Division (1880)
  3. Hematologic Malignancies, Division of (1188)
  4. GSK Faculty (1123)
  5. Department of Pathology and Laboratory Medicine (915)
  6. Epidemiology and Biostatistics (861)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (173)
  5. David Solit (166)
  6. Maria Carlo (165)

More People

Years
  1. 2025 (146)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (546)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (82)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (616)
  2. Elsevier Inc. (355)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (177)
  6. Oxford University Press (147)

More Publishers

Results (2561)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC
    Meeting Abstract

    Nishio, M.; Negrao, M. V.; Arbour, K. C.; Burns, T. F.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Hochmair, M.; Leal, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and clinicogenomic biomarkers of response to dual versus single agent checkpoint inhibitor therapy in untreated metastatic non-small cell lung cancer
    Meeting Abstract

    Boiarsky, D.; Hong, L.; Ricciuti, B.; Cooper, A. J.; Saad, M. B.; Elkrief, A.; Di Federico, A.; Aminu, M.; Rinsurongkawong, W.; Lewis, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary safety, pharmacokinetics and clinical activity of DFF332, an oral HIF2α inhibitor, as monotherapy in a phase 1 dose escalation study in patients with advanced clear cell renal cell carcinoma
    Meeting Abstract

    Pal, S. K.; Tannir, N. M.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; De Braud, F. G.; Takahashi, S.; Wong, A.; Suarez, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study
    Meeting Abstract

    Rojas, C.; Eskens, F.; Ghiringhelli, F.; Özgüroglu, M.; Caglevic, C.; Gumus, M.; Tosi, D.; Grenier, J.; Gonzalez, A. F.; Arenas, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC)
    Meeting Abstract

    Colevas, A. D.; Chung, C. H.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Sukari, A.; Worden, F. P.; Johnson, F. M.; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 safety and efficacy of IMC-F106C, a PRAME x CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM)
    Meeting Abstract

    Hamid, O.; Williams, A.; Lopez, J. S.; Olson, D.; Sato, T.; Shaw, H. M.; Friedman, C. F.; Thistlethwaite, F.; Middleton, M. R.; Lebbe, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C
    Meeting Abstract

    Sun, L.; Fayette, J.; Salas, S.; Hong, D. S.; Adkins, D.; Dunn, L.; Ciardiello, F.; Cirauqui, B.; William, W. N. Jr; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • First-in-human study of ABBV-706, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
    Meeting Abstract

    Chandana, S. R.; Choudhury, N. J.; Dowlati, A.; Chiang, A. C.; Garmezy, B.; Kim, J. H.; Byers, L. A.; Ahn, M. J.; Kim, T. M.; Kim, Y. C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • International medical graduates (IMG) representation at international oncology conference meetings
    Meeting Abstract

    Roy, A. M.; Bakouny, Z.; Dizman, N.; Ozay, Z. I.; Lal, B. M.; Nawfal, R.; Eid, M.; Chehade, R. E.; Machaalani, M.; Butt, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save